Skip to main content
OpenTrials

Clinical trial condition

Urinary Incontinence

Explore clinical trials studying Urinary Incontinence. Study availability and eligibility vary by location and protocol.

494 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Urinary Incontinence trial results

Completed

A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

NCT00137397

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Blackburn, Lancashire, United Kingdom
  • Pfizer Investigational Site Harrow, Middx, United Kingdom
  • Pfizer Investigational Site Oxford, Oxfordshire, United Kingdom
  • Pfizer Investigational Site Livingston, West Lothian, United Kingdom
View Trial Details
Completed

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

NCT00139724

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Beijing, Beijing Municipality, China
  • Pfizer Investigational Site Beijing, Beijing Municipality, China
  • Pfizer Investigational Site Huangzhou, Zhejiang, China
  • Pfizer Investigational Site Beijing, China
View Trial Details
Completed

Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.

NCT00230789

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Sun Lakes, Arizona, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Beverly Hills, California, United States
View all 51 locations
View Trial Details
Completed

Mirabegron For Erectile Dysfunction

NCT02916693

Conditions
Erectile Dysfunction, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
Locations
  • Johns Hopkins Medical Institutions Baltimore, Maryland, United States
View Trial Details

Related conditions